Table 1.
Parameter | Group | p Value | |
---|---|---|---|
ACE2 IgG antibodies | No ACE2 IgG antibodies | ||
Age (years), mean ± SD | 35.2 ± 5.9 | 36.9 ± 9.9 | >0.05 |
Women/men, % (n) | 23.6 (4)/76.4 (13) | 20.8 (233)/79.2 (889) | >0.05 |
Comorbidities, % (n) | 5.9 (1) | 6.8 (76) | >0.05 |
Influenza‐vaccinated in the 2019–2020 epidemic season, % (n) | 52.9 (9)/8 (47.1) | 57.9 (650)/42.1 (472) | >0.05 |